Pelvic-floor relaxation techniques using biofeedback – more effective therapy for chronic prostatitis/chronic pelvic pain syndrome

Abstract

Objective:

Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is characterized by pelvic pain and voiding symptoms, the management of which is challenging. The present study was designed to assess the efficacy of biofeedback and pelvic-floor relaxation treatment for CP/CPPS.

Methods:

A total of 84 patients diagnosed with CP/CPPS were randomly assigned to one of the two groups: conventional therapy (group A) and pelvic-floor muscle relaxation and biofeedback (group B). The Biofeedback and Electrical Stimulation apparatus was used for pelvic-floor muscle electrical stimulation and relaxation with biofeedback. National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) scores were evaluated at the start of therapy, after 3 months of treatment and at 6 months (3 months after last treatment received).

Results:

At 3 months, patients in both groups had a significant decrease (improvement in symptoms) in NIH-CPSI scoring. However, at 6 months, only 19 (47.5%) patients in group A maintained a fall in NIH-CPSI score >6 compared with 37 (94.8%) patients in group B (p<0.05). At 6 months, there was significant decrease in NIH-CPSI score in group B, whereas in group A, scores had increased (worsening of symptoms).

Conclusions:

Pelvic-floor muscle relaxation and biofeedback training is a safe and effective treatment for CP/CPPS with sustained efficacy.

Keywords

Chronic prostatitis/CPPS biofeedback conventional treatment pelvic-floor relaxation more effective

Get full access to this article

View all access options for this article.

References

Litwin

McNaughton-Collins

Fowler

Jr , et al. The National Institutes of Health Chronic Prostatitis Symptom Index: development and validation of a new outcome measure. J Urol 1999; 162: 369–375.

McNaughton Collins

MacDonald

Wilt

. Diagnosis and treatment of chronic abacterial prostatitis: a systematic review. Ann Intern Med 2000; 133: 367–381.

Nickel

Alexander

Anderson

, et al. Category III chronic prostatitis/chronic pelvic pain syndrome: insights from the National Institutes of Health Chronic Prostatitis Collaborative Research Network studies. Curr Urol Rep. 2008; 9(4): 320–327.

Wagenlehner

Van Till

Magri

, et al. National Institutes of Health Chronic Prostatitis Syndrome Index (NIH-CPSI) symptom evaluation in multinational cohorts of patients with chronic prostatitis/chronic pelvic pain syndrome. Eur Urol 2013; 64: 953–959.

Collins

Stafford

O’Leary

, et al. How common is prostatitis? A national survey of physician visits. J Urol 1998; 159: 1224–1228.

Zhong

HX.

Treatment of chronic bacterial prostatitis with amikacin through anal submucosal injection. Asian J Androl 2002; 4: 163–167.

Anothaisintawee

Attia

Nickel

, et al. Management of chronic prostatitis/chronic pelvic pain syndrome: a systematic review and network meta-analysis. JAMA 2011; 5: 78–86.

Propert

Litwin

Wang

, et al. Responsiveness of the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI). Qual Life Res 2006; 15: 299–305.

Lee

Muller

Rothman

, et al. Prostate biopsy cultures findings of men with chronic pelvic pain syndrome do not differ from those of healthy controls. J Urol 2003; 169: 584–587.

10.

Cheah

Liong

Yuen

, et al. Terazosin therapy for chronic prostatitis/chronic pelvic pain syndrome: a randomized placebo controlled trial. J Urol 2003; 169: 592–596.

11.

Mehik

Alas

Nickel

, et al. Alfuzosin treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, double-blind, placebo-controlled, pilot study. Urology 2003; 62: 425–429.

12.

Segura

Opitz

Greene

LF.

Prostatosis, prostatitis or pelvic floor tension myalgia?

J Urol 1979; 122: 168–169.

13.

Mazzoli

Conventional bacteriology in prostatitis patients: microbiological bias, problems and epidemiology on 1686 microbial isolates. Arch Ital Urol Androl 2007; 79: 71–75.

14.

Engeler

Baranowski

Dinis-Oliveira

, et al. The 2013 EAU guidelines on chronic pelvic pain: is management of chronic pelvic pain a habit, a philosophy, or a science? 10 years of development. Eur Urol 2013; 64: 431–439.

15.

Hetrick

Ciol

Rothman

, et al. Musculoskeletal dysfunction in men with chronic pelvic pain syndrome type III: a case control study. J Urol 2003; 170: 828–831.

16.

Zermann

D-H

Ishigooka

Doggweiler

, et al. Neurourological insights into the etiology of genitourinary pain in men. J Urol 1999; 161: 903–908.

17.

Cornel

Van Haarst

Schaarsberg

, et al. The effect of biofeedback physical therapy in men with chronic pelvic pain syndrome type III. Eur Urol 2005; 47: 607–611.

18.

Nickel

JC.

Effective office management of chronic prostatitis. Urol Clin North Am 1998; 25: 677–684.

19.

Britton

Jr Carson

CC.

Prostatitis. AUA Update Series 1998; 17: 154–159.

20.

Rosen

Seidmon

EJ.

Lower urinary tract infections in men. In Hanno

Wein

(eds) Clinical manual of urology. 2nd ed. New York: McGraw-Hill, 1994, pp.189–204.

21.

Kaplan

Santarosa

D’Alisera

, et al. Pseudodyssynergia (contraction of the external sphincter during voiding) misdiagnosed as chronic nonbacterial prostatitis and the role of biofeedback as a therapeutic option. J Urol 1997; 157: 2234–2237.

22.

Clemens

Nadler

Schaeffer

, et al. Biofeedback, pelvic floor re-education, and bladder training for male pelvic pain syndrome. Urology 2000; 56: 951–955.

23.

Yang

M-H

Huang

Y-H

Lai

Y-F

, et al. Comparing electromagnetic stimulation with electrostimulation plus biofeedback in treating male refractory chronic pelvic pain syndrome, Urol Sci 2017; 28: 156–161.

24.

Wenninger

Heiman

Rothman

, et al. Sickness impact of chronic nonbacterial prostatitis and its correlates. J Urol 1996; 155: 965–968.

25.

Kessler

Mordasini

Weisstanner

, et al. Sonoelectro-magnetic therapy for treating chronic pelvic pain syndrome in men: a randomized, placebo-controlled, double-blind trial. PLoS One 2014; 9: e113368.

26.

Kothari

Neuromodulatory approaches to chronic pelvic pain and coccygodynia. Acta Neurochir Suppl 2007; 97: 365–371.

27.

Goldfarb

Jamurtas

AZ.

Beta-endorphin response to exercise. An update. Sports Med 1997; 24: 8–16.